Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Markowska

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Ginekologia Polska|May 1, 1980
[Acid-base equilibrium in women with genital tumors and the effect of Co-60 therapy]T Tomaszkiewicz, J Markowska, Z Głogowska, et al.
Neoplasma|January 1, 1986
PHA responsiveness and adherent cell-lymphocyte interactions in patients with advanced malignant tumors of the ovary prior to treatment and during chemotherapyJ Markowska, J Jaroszewski, S Jankowiak, et al.
European Journal of Gynaecological Oncology|January 1, 1994
The value of estimating CA 125 in fluids from benign or malignant cysts, in the exudate and blood serum in women with ovarian cancerJ Markowska, Z Kopczyński, Z Szewierski, et al.
The International Journal of Biological Markers|October 9, 2007
Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examinationM Chechlinska, J Kaminska, J Markowska, et al.
Ginekologia Polska|March 1, 1993
[Survival, complications and quality of life in patients with breast cancer after ovariectomy and hormonal therapy]M Czub, J Markowska, P Tomczak, et al.
Ginekologia Polska|December 1, 1979
[Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP]S Simm, J Markowska, T Tomaszkiewicz, et al.
Clinical and Experimental Obstetrics & Gynecology|August 20, 2009
Activity of telomerase in ovarian cancer cells. Clinical implicationsJ Lubin, J Markowska, A Markowska, et al.
Clinical and Experimental Obstetrics & Gynecology|January 13, 2016
Oxidative stress markers in uterine fibroids tissue in pre- and postmenopausal womenA Markowska, M Mardas, E Gajdzik, et al.
Mutation Research|March 20, 1998
Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assayP Jałoszyński, M Kujawski, M Czub-Swierczek, et al.
European Journal of Gynaecological Oncology|April 15, 2003
Frequent disease progression and early recurrence in patients with familial ovarian cancer primarily treated with paclitaxel and cis- or carboplatin (preliminary report)A Wojciechowska-Lacka, J Markowska, E Skasko, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Ginekologia Polska|May 1, 1980
[Acid-base equilibrium in women with genital tumors and the effect of Co-60 therapy]T Tomaszkiewicz, J Markowska, Z Głogowska, et al.
Neoplasma|January 1, 1986
PHA responsiveness and adherent cell-lymphocyte interactions in patients with advanced malignant tumors of the ovary prior to treatment and during chemotherapyJ Markowska, J Jaroszewski, S Jankowiak, et al.
European Journal of Gynaecological Oncology|January 1, 1994
The value of estimating CA 125 in fluids from benign or malignant cysts, in the exudate and blood serum in women with ovarian cancerJ Markowska, Z Kopczyński, Z Szewierski, et al.
The International Journal of Biological Markers|October 9, 2007
Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examinationM Chechlinska, J Kaminska, J Markowska, et al.
Ginekologia Polska|March 1, 1993
[Survival, complications and quality of life in patients with breast cancer after ovariectomy and hormonal therapy]M Czub, J Markowska, P Tomczak, et al.
Ginekologia Polska|December 1, 1979
[Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP]S Simm, J Markowska, T Tomaszkiewicz, et al.
Clinical and Experimental Obstetrics & Gynecology|August 20, 2009
Activity of telomerase in ovarian cancer cells. Clinical implicationsJ Lubin, J Markowska, A Markowska, et al.
Clinical and Experimental Obstetrics & Gynecology|January 13, 2016
Oxidative stress markers in uterine fibroids tissue in pre- and postmenopausal womenA Markowska, M Mardas, E Gajdzik, et al.
Mutation Research|March 20, 1998
Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assayP Jałoszyński, M Kujawski, M Czub-Swierczek, et al.
European Journal of Gynaecological Oncology|April 15, 2003
Frequent disease progression and early recurrence in patients with familial ovarian cancer primarily treated with paclitaxel and cis- or carboplatin (preliminary report)A Wojciechowska-Lacka, J Markowska, E Skasko, et al.
Pageof 9